Dallas, TX -- (SBWIRE) -- 06/23/2015 -- RnRMarketResearch.com adds "Investigation Report on China Methylprednisolone Market, 2010-2019"to its store.
Ever since the 1990s, steroid has entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product restructuring and industrial development, steroid's Active Pharmaceutical Ingredients (APIs) made in China take an important position in the global market. Out of all the varieties of steroid's APIs, half are made in China.
As a variety performing well in hospitals in recent years, Methylprednisolone, driven by clinical needs and brand effects, shows a trend of steady growth. Developed by Pharmacia & Upjohn, Methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn).
The APIs and preparations of Methylprednisolone were first developed and marketed by Tianjin Tianyao Pharmaceuticals Co., Ltd in 2002. Methylprednisolone continues to grow after entering China with annual sales value rising from less than CNY 90 million in 2005 to CNY 295 million in 2014 and CAGR reaching up to 15%. Pharmacia & Upjohn (Belgium), Pharmacia & Upjohn (IT), Tianjin Tianyao Pharmaceuticals Co., Ltd , Pfizer
Manufacturing Beglium NV and Rongsheng Pharmaceutical Co., Ltd all take up certain shares in the Chinese market, among which Pfizer Manufacturing Beglium NV has the largest market share of 43.7% in 2014 for sales value while Pharmia & Upjohn (IT) has the largest market share of 54.9% for sales volume.
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=392841
The market size of Methylprednisolone in China is expected to keep growing in the next few years.
Readers can get at least the following information from this report:
-market size of Methylprednisolone in China
-market share of manufacturers of Methylprednisolone in China
-price of Methylprednisolone in Chinese market
-major manufacturers of Methylprednisolone in Chinese market
-market outlook of Methylprednisolone in China
The author suggests the following groups of people purchase this report:
-manufacturers of drugs for endocrine and metabolic regulation
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=392841
Table of Contents
1 Related Concepts of Methylprednisolone
1.2 Sales Status in Global Market
2 Market Profile of Methylprednisolone in China
2.1 Patent and Approval Status of Methylprednisolone in China
2.2 Major Manufacturers
2.3 Market Size
3 Survey on Sales Status of Methylprednisolone in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 Survey on Market Share of Major Manufacturers of Methylprednisolone in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 Survey on Dosage Forms of Methylprednisolone in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume